Clinical Trials in Atlanta

Showing 3341-3360 of 9,468 trials

Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant

NCT06337331

Patients eligible for a mismatch allogeneic stem cell transplant will receive Venetoclax daily for 7 days prior to transplant in addition to the following chemotherapy regimen: Decitabine daily for 5 days, Fludarabine daily for 5 days, and Busulfan daily for 2 days followed by 1 day of total body irradiation. Stem cell transplant will occur thereafter.

Acute Myeloid LeukemiaMyelodysplastic Syndromes

Northside Hospital, Inc.Started Aug 2024

Atlanta, Georgia, United States

TERMINATEDPhase 1/2< 1 mile

Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations

NCT04161391

A phase 1/2, first-in-human, open-label study to determine the safety, tolerability, PK, and preliminary efficacy of the novel RET/SRC inhibitor TPX-0046 in adult subjects with advanced or metastatic solid tumors harboring RET mutations or alterations. The study consists of three portions: 1) Phase 1 Dose Escalation and Food Effect Sub-study, and 2) Phase 1 dose expansion and 3) Phase 2 efficacy evaluation.

Non Small Cell Lung CancerMedullary Thyroid CancerRET Gene Mutation+2 more

Turning Point Therapeutics, Inc.41 participantsStarted Dec 2019

La Jolla, California, United States • Orange, California, United States • Aurora, Colorado, United States +18 more locations

Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant

Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations

Find Trials by Condition in Atlanta

HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer

A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat

Improving Veteran Adherence to Treatment for PTSD Through Partnering With Families

Dry Needling and Spinal Manipulation vs. Conventional PT for Lumbar Spinal Stenosis

Tolerability, Safety and Efficacy of a New Frequency of Vibrant Capsule Administration

A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma

Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-301)

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Bridge to HOPE: Hypothermic Oxygenated Perfusion Versus Cold Storage Prior to Liver Transplantation

Trim II for Noninvasive Lipolysis and Circumference Reduction of Abdomen.

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)

Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

A Study to Evaluate LB1148 for Return of Bowel Function in Subjects Undergoing Bowel Resection

Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants

A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3

Trial for Treatment Refractory Trigeminal Neuralgia

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients